ESC 365 - SGLT2 inhibition & heart failure: lessons and implications from EMPA-REG OUTCOME.

HFA Premium Access

SGLT2 inhibition & heart failure: lessons and implications from EMPA-REG OUTCOME.

Session: Heart failure, diabetes, and renal dysfunction: time for a more unified approach

Topic: Chronic Ischaemic heart disease

Speaker: Doctor P. Groop

Sponsored by PACE-CME -- Boehringer-Ingelheim/Lilly

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Per-Henrik Groop

3 presentations

0 follower

1 more presentation in this session

Discussion.

Speaker: Professor A. Voors (Groningen, NL) Professor M. Cowie (Cambridge, GB) Doctor P. Groop Professor J. McMurray (Glasgow, GB)

Access the full session

Heart failure, diabetes, and renal dysfunction: time for a more unified approach

Speakers: Doctor P. Groop, Professor A. Voors, Professor M. Cowie, Doctor P. Groop, Professor J. McMurray

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources